Imago BioSciences raised $40 mln
Imago BioSciences Inc said March 21 that it raised $40 million in Series B financing led by Omega Funds. Participating in the round were Frazier Healthcare Partners, Amgen Ventures, and MRL Ventures Fund as well as HighLight Capital, Pharmaron and Greenspring Associates. Imago BioSciences is a clinical-stage biotechnology company developing treatments for myeloid diseases.
21 March 2019•3 mins read
